Skip to main content
. 2022 Oct 26;11(21):3387. doi: 10.3390/cells11213387

Table 4.

Uni/multi-variate logistic regression analysis of factors associated with high-grade fibrosis.

Univariable Logistic Regression
Variable n Coefficient Se (Coefficient) Odds Ratio (95% CI) p-Value
CD68_HLA-DR_OX40L_Phospho-c-RAF_STING_Tim-3 (low vs. high) 64 4.178 0.859 65.25 (12.11–351.49) 1.16 × 10−6
Age (≤55 years vs. >55 years) 64 −0.945 0.543 0.39 (0.13–1.13) 0.082
Sex (male vs. female) 64 −0.714 0.568 0.49 (0.16–1.49) 0.208
Etiology
CHB (absent vs. present) 64 0.397 0.559 1.49 (0.50–4.45) 0.477
CHC (absent vs. present) 64 −16.695 1696.734 0.00 (0.00–Inf) 0.992
Alcohol (absent vs. present) 64 −0.507 0.949 0.60 (0.09–3.87) 0.593
Others (absent vs. present) 64 0.145 0.665 1.16 (0.31–4.25) 0.828
BMI (≤25 kg/m2 vs. >25 kg/m2) 64 1.122 0.575 3.07 (0.99–9.48) 0.051
Diabetes (absent vs. present) 64 0.734 0.586 2.08 (0.66–6.57) 0.210
ALT (<31(F), <41(M) IU/L vs. ≥31(F), ≥41(M) IU/L) 64 0.029 0.513 1.03 (0.38–2.81) 0.955
AST (<31(F), <37(M) IU/L vs. ≥31(F), ≥37(M) IU/L) 64 −0.029 0.513 0.97 (0.36–2.65) 0.955
GGT (<50 IU/L vs. 50 IU/L) 58 0.462 0.603 1.59 (0.49–5.17) 0.443
Albumin (<4.0 g/dL vs. 4.0 g/dL) 64 0.366 0.511 1.44 (0.53–3.92) 0.475
Platelets (<150 × 109/L vs. ≥150 × 109/L) 64 −0.463 0.532 0.63 (0.22–1.79) 0.384
Cholesterol (<200 mg/dL vs. ≥200 mg/dL) 62 0.256 0.650 1.29 (0.36–4.62) 0.693
Multivariable Logistic Regression
Variable Coefficient Odds Ratio (95% CI) p -Value
CD68_HLA-DR_OX40L_Phospho-c-RAF_STING_Tim-3 (Low vs. High) 4.646 104.13 (14.29–758.66) 4.54 × 10−6
Age (≤55 years vs. >55 years) −0.558 0.57 (0.10–3.29) 0.532
BMI (≤25 kg/m2 vs. >25 kg/m2) 2.097 8.15 (1.28–51.93) 0.026

Abbreviation: ALT, alanine aminotransferase; AST, aspartate aminotransferase; body mass index, BMI; chronic hepatitis B, CHB; chronic hepatitis C, CHC; CI, confidence interval; gamma glutamyl transferase, GGT.